Lactobacillus acidophilus La5 and bifidobacterium lactis BB12 induce different age-related metabolic profiles revealed by 1H-NMR spectroscopy in urine and feces of mice1-3

Journal of Nutrition

Volumn 143, Issue 10, 2013, Pages 1549-1557

  Brasili, Elisa ^a   Mengheri, Elena ^a   Tomassini, Alberta ^b   Capuani, Giorgio ^c   Roselli, Marianna ^a   Finamore, Alberto ^a   Sciubba, Fabio ^b   Marini, Federico ^b   Miccheli, Alfredo ^b,c  

^a ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYPHENYLACETIC ACID; DIMETHYLGLYCINE; HOMOCYSTEINE; N METHYLNICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINIC ACID; PHOSPHATE BUFFERED SALINE; PROBIOTIC AGENT; SARCOSINE; VALERIC ACID; XYLOSE;

ANALYSIS; ANIMAL EXPERIMENT; ARTICLE; BIFIDOBACTERIUM ANIMALIS; COLONY FORMING UNIT; CONTROLLED STUDY; FECES; LACTOBACILLUS ACIDOPHILUS; MALE; METABOLISM; METABOLITE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; URINE;

AGE FACTORS; AGING; ANIMALS; BIFIDOBACTERIUM; FECES; HOMOCYSTEINE; INTESTINES; LACTOBACILLUS ACIDOPHILUS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; MICE; MICE, INBRED BALB C; NAD; NIACIN; NIACINAMIDE; PENTANOIC ACIDS; PHENYLACETATES; PROBIOTICS; SARCOSINE; XYLOSE;

EID: 84885828394     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.113.177105     Document Type: Article

References (69)

1. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S. Host-gut microbiota metabolic interactions. Science. 2012;336:1262-7.
2. Haller D, Antoine JM, Bengmark S, Enck P, Rijkers GT, Lenoir-Wijnkoop I. Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome. J Nutr. 2010;140 Suppl:690S-7S.
3. Kalliomäki M, Antoine JM, Herz U, Rijkers GT, Wells JM, Mercenier A. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. J Nutr. 2010;140 Suppl:713S-21S.
4. Roselli M, Finamore A, Britti MS, Konstantinov SR, Smidt H, de Vos WM, Mengheri E. The novel porcine Lactobacillus sobrius strain protects intestinal cells from enterotoxigenic Escherichia coli K88 infection and prevents membrane barrier damage J Nutr. 2007;137: 2709-16.
5. Finamore A, Roselli M, Britti MS, Merendino N, Mengheri E. Lactobacillus rhamnosus GG and Bifidobacterium animalis MB5 induce intestinal but not systemic antigen-specific hyporesponsiveness in ovalbumin-immunized rats. J Nutr. 2012;142:375-81.
6. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol. 2007;5:e177.
7. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev. 2010;90:859-904.
8. Malinen E, RinttiläT, Kajander K, MättöJ, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol. 2005;100:373-82.
9. Gentschew L, Ferguson LR. Role of nutrition and microbiota in susceptibility to inflammatory bowel disease. Mol Nutr Food Res. 2012;56:524-35.
10. Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, Sørensen SJ, Hansen LH, Jakobsen M. Gut microbiota in human adults with type 2 diabetes differs from nondiabetic adults. PLoS ONE. 2010;5:e9085.
11. Musso G, Gambino R, Cassader M. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care. 2010;33:2277-84.
12. Hopkins MJ, Macfarlane GT. Changes in predominant bacterial populations in human feces with age and with Clostridium difficile infection. J Med Microbiol. 2002;51:448-54.
13. Woodmansey EJ, McMurdo MET, Macfarlane CT, Macfarlane S. Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic treated elderly subjects. Appl Environ Microbiol. 2004;70:6113-22.
14. Mueller S, Saunier K, Hanisch C, Norin E, Alm L,Midtvedt T, Cresci A, Silvi S, Orpianesi C, Verdenelli MC, et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol. 2006;72:1027-33.
15. Franceschi C. Inflammaging as a major characteristic of old people: can it be prevented or cured? Nutr Rev. 2007;65:S173-6.
16. Biagi E, Candela M, Fairweather-Tait S, Franceschi C, Brigidi P. Aging of the human metaorganism: the microbial counterpart. Age (Dordr). 2012;34:247-67.
17. Finamore A, Roselli M, Mengheri E. Alterations of immune function and gut microbiota with ageing: can probiotic supplementation counteract these changes? Food Sci Technol Bull. 2009;6:51-9.
18. Mocchegiani E, Corsonello A, Lattanzio F. Frailty, ageing and inflammation: reality and perspectives. Biogerontology. 2010;11:523-5.
19. Woodmansey EJ. Intestinal bacteria and ageing. J Appl Microbiol. 2007;102:1178-86.
20. Turchet P, Laurenzano M, Auboiron S, Antoine JM. Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in freeliving elderly subjects: a randomised, controlled pilot study. J Nutr Health Aging. 2003;7:75-7.
21. Rauch M, Lynch SV. Probiotic manipulation of the gastrointestinal microbiota. Gut Microbes. 2010;1:335-8.
22. Guillemard E, Tondu F, Lacoin F, Schrezenmeir J. Consumption of a fermented diary product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. Br J Nutr. 2010;103:58-68.
23. Rampelli S, Candela M, Severgnini M, Biagi E, Turroni S, Roselli M, Carnevali P, Donini L, Brigidi P. A probiotics-containing biscuit modulates the intestinal microbiota in the elderly. J Nutr Health Aging. 2013;17:166-72.
24. Martin FP, Wang Y, Sprenger N, Yap IK, Lundstedt T, Lek P, Rezzi S, Ramadan Z, van Bladeren P, Fay LB, et al. Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol Syst Biol. 2008;4:157.
25. Martin FP, Wang Y, Sprenger N, Holmes E, Lindon JC, Kochhar S, Nicholson JK. Effects of probiotic Lactobacillus paracasei treatment on the host gut tissue metabolic profiles probed via magic-angle-spinning NMR spectroscopy. J Proteome Res. 2007;6:1471-81.
26. Martin FP, Wang Y, Sprenger N, Yap IK, Rezzi S, Ramadan Z, Peré-Trepat E, Rochat F, Cherbut C, van Bladeren P, et al. Top-down systems biology integration of conditional prebiotic modulated transgenomic interactions in a humanized microbiome mouse model. Mol Syst Biol. 2008;4:205.
27. Martin FP, Verdu EF, Wang Y, Dumas ME, Yap IK, Cloarec O, Bergonzelli GE, Corthesy-Theulaz I, Kochhar S, Holmes E, et al. Transgenomic metabolic interactions in a mouse disease model: interactions of Trichinella spiralis infection with dietary Lactobacillus paracasei supplementation. J Proteome Res. 2006;5:2185-93.
28. Martin FP, Collino S, Rezzi S. 1H NMR-based metabonomic applications to decipher gut microbial metabolic influence on mammalian health. Magn Reson Chem. 2011; 49 Suppl 1:S47-54.
29. Claus SP, Tsang TM, Wang Y, Cloarec O, Skordi E, Martin FP, Rezzi S, Ross A, Kochhar S, Holmes E, et al. Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol Syst Biol. 2008;4:219.
30. Martin FP, Dumas ME, Wang Y, Legido-Quigley C, Yap IK, Tang H, Zirah S, Murphy GM, Cloarec O, Lindon JC, et al. A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol Syst Biol. 2007;3:112.
31. Martin FP, Wang Y, Yap IK, Sprenger N, Lindon JC, Rezzi S, Kochhar S, Holmes E, Nicholson JK. Topographical variation in murine intestinal metabolic profiles in relation to microbiome speciation and functional ecological activity. J Proteome Res. 2009;8:3464-74.
32. Calvani R, Miccheli A, Capuani G, Tomassini Miccheli A, Puccetti C, Delfini M, Iaconelli A, Nanni G, Mingrone G. Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype. Int J Obes (Lond). 2010;34:1095-8.
33. Saric J, Wang Y, Li J, Coen M, Utzinger J, Marchesi JR, Keiser J, Veselkov K, Lindon JC, Nicholson JK, et al. Species variation in the fecal metabolome gives insight into differential gastrointestinal function. J Proteome Res. 2008;7:352-60.
34. Savard P, Lamarche B, Paradis ME, Thiboutot H, Laurin É , Roy D. Impact of Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults. Int J Food Microbiol. 2011;149:50-7.
35. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V, Akbarian-Moghari A. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipidprofile in individuals with type 2 diabetes mellitus. J Dairy Sci. 2011; 94:3288-94.
36. Wang KY, Li SN, Liu CS, Perng DS, Su YC, Wu DC, Jan CM, Lai CH, Wang TN, Wang WM. Effects of ingesting Lactobacillus-and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr. 2004;80:737-41.
37. Chapman CM, Gibson GR, Rowland I. In vitro evaluation of singleand multi-strain probiotics: inter-species inhibition between probiotic strains, and inhibition of pathogens. Anaerobe. 2012;18:405-13.
38. Fan TWM. Metabolite profiling by one-and two-dimensional NMR analysis of complex mixtures. Prog Nucl Magn Reson Spectrosc. 1996;28:161-219.
39. Fan TWM, Lane AN. Structure-based profiling of metabolites and isotopomers by NMR. Prog Nucl Magn Reson Spectrosc. 2008;52:69-117.
40. Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, Djoumbou Y, Mandal R, Aziat F, Dong E, et al. HMDB 3.0-the human metabolome database in 2013. Nucleic Acids Res. 2013;41:D801-7.
41. Barker M, Rayens W. Partial least squares for discrimination. J Chemometr. 2003;17:166-73.
42. Westad F, Afseth NK, Bro R. Finding relevant spectral regions between spectroscopic techniques by use of cross model validation and partial least squares regression. Anal Chim Acta. 2007;595:323-7.
43. Westerhuis JA, Hoefsloot HCJ, Smit S, Vis DJ, Smilde AK, van Velzen EJJ, van Duijnhoven JPM, van Dorsten FA. Assessment of PLS-DA cross-validation. Metabolomics. 2008;4:81-9.
44. Wold S, Johansson E, Cocchi M. PLS-partial least squares to latent structures. In: Kubinyi H, editor. 3D QSAR in drug design. Leiden (The Netherlands): ESCOM Science Publishers; 1993. p. 523-50.
45. Smilde AK, Jansen JJ, Hoefsloot HCJ, Lamers RJAN, van der Greef J, Timmerman ME. ANOVA-simultaneous component analysis (ASCA): a new tool for analyzing designed metabolomics data. Bioinformatics. 2005;21:3043-8.
46. Westerhuis JA, van Velzen EJJ, Hoefsloot HCJ, Smilde AK. Discriminant Q2 (DQ2) for improved discrimination in PLSDA models. Metabolomics. 2008;4:293-6.
47. Niculescu MD, Zeisel SH. Diet, methyl donors and DNA methylation: interactions between dietary folate, methionine and choline. J Nutr. 2002;132:2333S-5S.
48. Craig SA. Betaine in human nutrition. Am J Clin Nutr. 2004;80:539-49.
49. Olthof MR, Brink EJ, Katan MB, Verhoef P. Choline supplemented as phosphatidylcholine decreases fasting and postmethionine-loading plasma homocysteine concentrations in healthy men. Am J Clin Nutr. 2005;82:111-7.
50. Finkelstein JD, Martin JJ, Harris BJ, Kyle WE. Regulation of hepatic betaine-homocysteine methyltransferase by dietary betaine. J Nutr. 1983;113:519-21.
51. Ellinson M, Thomas J, Patterson A. A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly. J Hum Nutr Diet. 2004;17: 371-83.
52. Selhub J. Homocysteine metabolism. Annu Rev Nutr. 1999;19:217-46.
53. Swift ME, Kleinman HK, DiPietro LA. Impaired wound repair and delayed angiogenesis in aged mice. Lab Invest. 1999;79:1479-87.
54. Teng YW, Cerdena I, Zeisel SH. Homocysteinemia in mice with genetic betaine homocysteine S-methyltransferase deficiency is independent of dietary folate intake. J Nutr. 2012;142:1964-7.
55. Martin FP, Sprenger N, Yap IK, Wang Y, Bibilioni R, Rochat F, Rezzi S, Cherbut C, Kochhar S, Lindon JC, et al. Panorganismal gut microbiome-host metabolic crosstalk. J Proteome Res. 2009;8:2090-105.
56. Rouleau M, Patel A, Hendzel MJ, Kaufmann SH, Poirier GG. PARP inhibition: PARP1 and beyond. Nat Rev Cancer. 2010;10:293-301.
57. Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature. 2009;460:587-91.
58. Imai S. ''Clocks'' in the NAD World: NAD as a metabolic oscillator for the regulation of metabolism and aging. Biochim Biophys Acta. 2010; 1804:1584-90.
59. Imai S. The NAD World: a new systemic regulatory network for metabolism and aging-Sirt1, systemic NAD biosynthesis, and their importance. Cell Biochem Biophys. 2009;53:65-74.
60. Nevedomskaya E, Meissner A, Goraler S, de Waard M, Ridwan Y, Zondag G, van der Pluijm I, Deelder AM, Mayboroda OA. Metabolic profiling of accelerated aging ERCC1 d/-mice. J Proteome Res. 2010;9:3680-7.
61. Schneider H, Simmering R, Hartmann LP, Forte H, Blaut M. Degradation of quercetin-3-glucoside in gnotobiotic rats associated with human intestinal bacteria. J Appl Microbiol. 2000;89:1027-37.
62. Griffiths LA, Barrow A. Metabolism of flavonoid compounds in germfree rats. Biochem J. 1972;130:1161-2.
63. Nakagawa Y, Ashetlar MR, Wender SH. Urinary products from quercetin in neomycin-treated rats. Biochim Biophys Acta. 1965;97: 233-41.
64. Lee HC, Jenner AM, Low CS, Lee YK. Effect of tea phenolics and their aromatic fecal bacterial metabolites on intestinal microbiota. Res Microbiol. 2006;157:876-84.
65. Cueva C, Moreno-Arribas MV, Martín-Alvarez PJ, Bills G, Vicente MF, Basilio A, Rivas CL, Requena T, Rodríguez JM, Bartolomé B. Antimicrobial activity of phenolic acids against commensal, probiotic and pathogenic bacteria. Res Microbiol. 2010;161:372-82.
66. Tian Y, Zhang L,Wang Y, Tang H. Age-related topographical metabolic signatures for the rat gastrointestinal contents. J Proteome Res. 2012; 11:1397-411.
67. Pokusaeva K, Fitzgerald GF, van Sinderen D. Carbohydrate metabolism in bifidobacteria. Genes Nutr. 2011;6:285-306.
68. Mäkeläinen H, Saarinen M, Stowell J, Rautonen N, Ouwehand AC. Xylo-oligosaccharides and lactitol promote the growth of Bifidobacterium lactis and Lactobacillus species in pure cultures. Benef Microbes. 2010;1:139-48.
69. [cited 2012 Dec]. Available from: http://www.kegg.jp/kegg/pathway.html.